Bracco Imaging, a global leader in diagnostic imaging, today announced the commercial availability of VUEWAY® injection (gadopiclenol), which received approval in September 2025 from the Federal ...
Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has launched Gadoterate Meglumine Injection, USP, a bioequivalent and therapeutic equivalent substitute for the contrast agent ...
CMS has permanently authorized virtual contrast supervision beginning January 1, 2026, allowing radiologists to oversee contrast injections via real-time audio and video technology. Professional ...
A new artificial-intelligence technology for heart imaging can potentially improve care for patients, allowing doctors to examine their hearts for scar tissue while eliminating the need for contrast ...
A new artificial-intelligence technology for heart imaging can improve care for patients, allowing doctors to examine their hearts for scar tissue while eliminating the need for contrast injections. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results